The Trials of Hypertension Prevention (TOHP) is a collaborative multicentered research program designed to test the feasibility and short-term effectiveness of selected nutritional and behavioral non-pharmacologic interventions in reducing or preventing an increase in diastolic blood pressure (DBP) in normotensive individuals. The information regarding the efficacy, safety and feasibility of the multiple interventions tested in Phase I would be used to assess the potential benefit of proceeding to a full-scale trial, Phase II, the objective of which would be to determine the effectiveness of the most promising of these therapies in reducing the incidence of frank hypertension. As the Coordinating Center, in conjunction with the Planning Committee, we would play a collaborative role in the design, conduct and analysis of the trial. During the 9-month planning period (Phase 1A), our major responsibility would be to coordinate the efforts of the Planning Committee in preparing for the start-up of the trial at the clinical centers. Specific activities would include the development of standardized trial materials including the study protocol, data forms, and a detailed Manual of Operations, as well as the training and certification of clinical center personnel. We would also assume responsibility for designing and implementing data processing and management programs. During the implementation period (Phase 1B), the Coordinating Center would be responsible for integrating the activities of the various collaborating units of the study (e.g., clinical centers, central laboratory, NHLBI). Major functions would include: (1) the collection, receipt, quality control, and analysis of data; (2) serving as the major interface with the clinical centers; and (3) facilitating the activities of all supervisory committees. Thus, the Coordinating Center will serve a proactive and collaborative role as an epidemiologic, statistical, clinical, and data management resource.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL037852-03
Application #
3552809
Study Section
(SRC)
Project Start
1986-09-30
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Cook, Nancy R; Appel, Lawrence J; Whelton, Paul K (2014) Lower levels of sodium intake and reduced cardiovascular risk. Circulation 129:981-9
Cook, Nancy R; Obarzanek, Eva; Cutler, Jeffrey A et al. (2009) Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 169:32-40
Cook, Nancy R; Cutler, Jeffrey A; Obarzanek, Eva et al. (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334:885-8
Cook, N R (2006) Imputation strategies for blood pressure data nonignorably missing due to medication use. Clin Trials 3:411-20
Kumanyika, S K; Cook, N R; Cutler, J A et al. (2005) Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens 19:33-45
Cook, N R; Kumanyika, S K; Cutler, J A et al. (2005) Dose-response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens 19:47-54
Stevens, V J; Obarzanek, E; Cook, N R et al. (2001) Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 134:1-11
Hunt, S C; Cook, N R; Oberman, A et al. (1998) Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 32:393-401
Cook, N R; Kumanyika, S K; Cutler, J A (1998) Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. Am J Epidemiol 148:431-44
(1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborativ Arch Intern Med 157:657-67

Showing the most recent 10 out of 25 publications